Based on the news about the stock in the past five trading days, please predict the rise or fall of the stock in the next trading day. If the stock is predicted to rise in the next trading day, please output [Rise], if the stock is predicted to fall in the next trading day, please output [Decrease].

Date:2020-05-08, Stock:ABBV, The news for the past five days is as follows:
2020-05-01: NEWS1: AbbVie Beats 1st-Quarter Estimates, Keeps 2020 Guidance.NEWS2: AbbVie's Humira Puts Up Strong Showing, But Allergan Questions Linger.NEWS3: AbbVie's Humira Puts Up Strong Showing, But Allergan Questions Linger.NEWS4: AbbVie Inc (ABBV) Q1 2020 Earnings Call Transcript.NEWS5: AbbVie Posts First-Quarter Earnings Beat on Strong Humira Sales.NEWS6: AbbVie Beats Q1 Estimates as U.S. Humira Sales Rise 13.7%.NEWS7: AbbVie's (ABBV) Q1 Earnings and Sales Surpass Estimates.NEWS8: AbbVie Beats Earnings Estimates as Allergan Acquisition Nears.NEWS9: Recap: AbbVie Q1 Earnings.NEWS10: AbbVie tops earnings estimates, sticks with 2020 guidance.NEWS11: AbbVie Earnings Top; Drug Giant Edges Higher.NEWS12: AbbVie Reports First-Quarter 2020 Financial Results.NEWS13: Amazon, Apple, Exxon, AbbVie and Gilead - 5 Things You Must Know Friday.NEWS14: Form 8.3 - ABBVIE PLC.
2020-05-04: NEWS1: Trump expresses confidence for coronavirus vaccine ‘by the end of the year’.NEWS2: Stock Market Today With Jim Cramer: Time to Sell Stocks?.NEWS3: AbbVie Reaffirms Plan To Buy Allergan In May — Is AbbVie Stock A Buy?.NEWS4: Form 8.3 - ABBVIE PLC AMENDMENT.NEWS5: Form 8.3 - ABBVIE INC - Amendment.NEWS6: Form 8.3 - AbbVie Inc..NEWS7: Form 8.3 - Abbvie Plc - Amendment.NEWS8: Drugmaker AbbVie Reiterates 2020 Guidance, Beats Quarterly Sales.NEWS9: Form 8.3 - ABBVIE INC.NEWS10: Form 8.3 - AbbVie Inc..
2020-05-05: NEWS1: Abbvie's deal for Allergan clears U.S. antitrust hurdle.NEWS2: Abbvie's deal for Allergan clears U.S. antitrust hurdle.NEWS3: AbbVie and Allergan Receive Clearance from U.S. Federal Trade Commission for AbbVie's Acquisition of Allergan.NEWS4: Form 8.3 - AbbVie Inc..NEWS5: AbbVie Receives Health Canada Approval for the Combination of VENCLEXTA® (venetoclax) with Obinutuzumab for Patients with Previously Untreated Chronic Lymphocytic Leukemia.NEWS6: Form 8.3 - ABBVIE INC.
2020-05-06: NEWS1: DexCom & Domino's Pizza Set to Join S&P 500; Salesforce.com to Join S&P 100; STORE Capital to Join S&P MidCap 400; Capri Holdings to Join S&P SmallCap 600.NEWS2: 3 Dividend Stocks Perfect for Retirees.NEWS3: The Charts of AbbVie Can Reach New Heights.NEWS4: Form 8.3 - Abbvie Inc - Amendment.NEWS5: AbbVie's Pending Acquisition of Allergan Earns FTC Approval.NEWS6: AbbVie's Pending Acquisition of Allergan Earns FTC Approval.NEWS7: The Daily Biotech Pulse: FDA Nod For AstraZeneca, AbbVie-Allergan Deal Clears Antitrust Hurdle.NEWS8: US regulator clears AbbVie’s $63bn deal for Allergan.NEWS9: Form 8.3 - Abbvie Inc.NEWS10: Form 8.3 - AbbVie Inc..NEWS11: AbbVie Scores US Antitrust Approval for $63B Allergan Deal.NEWS12: AbbVie wins U.S. antitrust approval to buy Allergan.NEWS13: AbbVie Announces Extension of Expiration Date for Exchange Offers for Allergan Notes and Expects No Further Extensions of Expiration Date.
2020-05-07: NEWS1: Form 8.3 - AbbVie Inc..NEWS2: Form 8.3 - Abbvie Inc.

Answer: Decrease